UPDATED Apr 17, 2024
Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NEWBRY | kr3.50 | 2.6% | -39.4% | kr84.9m | kr8.00 | PS3.7x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
HDG | ₫26,000.00 | -8.9% | 3.8% | ₫7.9t | ₫32,300.00 | PE12x | E31.4% | 0% | Capital Goods | ||
GTHX | US$4.28 | -8.0% | 44.6% | US$213.0m | US$8.50 | PS2.7x | E55.1% | n/a | Pharmaceuticals & Biotech | ||
ZVRA | US$4.64 | -5.7% | -23.4% | US$199.6m | US$19.00 | PS7.1x | E63.6% | n/a | Pharmaceuticals & Biotech | ||
RCEL | US$9.38 | -35.0% | -35.6% | US$250.3m | US$26.90 | PS4.8x | E63.5% | n/a | Pharmaceuticals & Biotech | ||
CALTX | kr100.90 | -9.3% | -20.9% | kr5.4b | kr208.00 | PS4.5x | E48.8% | n/a | Pharmaceuticals & Biotech | ||
NOHAL | kr23.00 | 4.5% | -1.7% | kr899.4m | kr32.50 | PS8.8x | E56.0% | n/a | Food, Beverage & Tobacco | ||
ELABS | kr13.92 | -2.0% | 2.2% | kr1.5b | kr25.00 | PS21.4x | E124.6% | n/a | Software | ||
MVW | kr8.50 | -0.6% | 1.4% | kr248.2m | kr12.20 | PS22.5x | E66.0% | n/a | Materials | ||
KEBNI B | kr1.56 | -0.5% | 37.5% | kr421.9m | kr1.80 | PS5.9x | E96.2% | n/a | Tech | ||
AVLL3 | R$3.86 | 0.8% | 28.7% | R$754.0m | R$9.90 | PS1.6x | E101.9% | n/a | Consumer Durables | ||
NVG | zł2.42 | -3.2% | 61.3% | zł84.7m | zł3.71 | PE8.7x | E28.5% | n/a | Diversified Financials | ||
GIG | kr34.70 | 2.1% | 28.5% | kr4.5b | kr49.20 | PE28.5x | E39.8% | n/a | Consumer Services | ||
FDE | €32.00 | -7.9% | -14.7% | €167.4m | €64.07 | PE21.3x | E32.3% | n/a | Energy | ||
WAYS | kr23.50 | -1.3% | -48.5% | kr189.6m | kr39.75 | PS1.7x | E81.8% | 0% | Tech | ||
GWIND | ₺25.52 | 0.2% | 53.2% | ₺13.8b | ₺39.79 | PE22.1x | E60.9% | 1.8% | Utilities | ||
ATAKP | ₺45.96 | -2.2% | n/a | ₺6.4b | ₺67.66 | PE21.6x | E72.8% | n/a | Food, Beverage & Tobacco | ||
AGP | €7.64 | -5.0% | 105.4% | €132.3m | €12.75 | PE26.9x | E22.8% | n/a | Capital Goods | ||
RDUE | €9.50 | -2.1% | -2.1% | €59.4m | €11.70 | n/a | E42.0% | n/a | Capital Goods | ||
OSE | €4.88 | 4.8% | -0.4% | €105.1m | €7.15 | PS47.2x | E92.9% | n/a | Pharmaceuticals & Biotech | ||
A211050 | ₩4,900.00 | 5.6% | 126.2% | ₩241.6b | ₩3,800.00 | PE8.2x | E41.8% | 1.4% | Insurance | ||
5038 | JP¥1,424.00 | 0.6% | -35.9% | JP¥20.6b | n/a | PE34.8x | E24.7% | n/a | Healthcare | ||
A254490 | ₩18,810.00 | -6.2% | -27.7% | ₩271.6b | n/a | PE53.6x | E75.7% | n/a | Tech | ||
A108860 | ₩16,210.00 | -3.0% | -16.6% | ₩436.3b | n/a | PS8.2x | E98.9% | n/a | Software |